enGene Therapeutics Inc. - 8-K Filing

Dr. Richard Glickman resigns as chairman of enGene Therapeutics Inc., succeeded by Michael Heffernan (Items: 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Offi, 7.01 Regulation FD Disclosure, 9.01 Financial Statements and Exhibits)

SEC EDGAR · July 16, 2026, 12:07 UTC

Tickers: $ENGN

Read the full article at SEC EDGAR

More Regulatory news

NVIDIA CORP - 8-K Filing SEC EDGAR · November 12, 2026, 13:52 UTC
COVENANT LOGISTICS GROUP, INC. - 8-K Filing SEC EDGAR · November 12, 2026, 13:52 UTC
CuriosityStream Inc. - 10-Q Filing SEC EDGAR · November 12, 2026, 13:52 UTC
Star Equity Holdings, Inc. - 8-K Filing SEC EDGAR · November 12, 2026, 13:52 UTC
DeFi Development Corp. - 10-Q Filing SEC EDGAR · November 12, 2026, 13:51 UTC
BALTIC INTERNATIONAL USA INC - 10-Q Filing SEC EDGAR · November 12, 2026, 13:49 UTC
Forbright, Inc. - 8-K Filing SEC EDGAR · November 12, 2026, 13:50 UTC
Boxlight Corp - 8-K Filing SEC EDGAR · November 12, 2026, 13:50 UTC
CuriosityStream Inc. - 8-K Filing SEC EDGAR · November 12, 2026, 13:49 UTC
BORGWARNER INC - 8-K Filing SEC EDGAR · November 12, 2026, 13:47 UTC